Skip to main content
SpringerLink
Log in

Perioperative matrix metalloproteinase inhibition therapy does not impair wound or anastomotic healing

  • Published:
Journal of Gastrointestinal Surgery

Abstract

Matrix metalloproteinases (MMPs) catalyze the degradation of collagen and extracellular matrix. They play a role in pathologic states including malignancy, in which they facilitate invasion and metastasis. MMP inhibition has been shown to block neoplastic invasion and improve survival in animal models of malignancy. Concern about the effects of MMP inhibitors on wound and anastomotic healing may limit their potential use in the perioperative period to prevent local and systemic showering of cancer cells from surgical manipulation. We sought to assess the safety of perioperative administration of an MMP inhibitor (BB-94) with respect to skin and bowel healing in a rat model. Absorption of BB-94 was confirmed through high-pressure liquid chromatography and mass spectroscopy of sera from treated animals. Bowel bursting pressure in all animals increased almost 10-fold between 4 and 14 days. Two-way analysis of variance showed no significant difference in bowel bursting pressure between control and treatment animals over time. There was a significant increase in the collagen content of skin specimens of all animals combined between 4 and 28 days. Similarly, all animals showed an increase in bowel collagen between 4 and 28 days. There was no significant difference in skin or bowel collagen concentrations between control and treatment animals over time. Perioperative treatment with MMP inhibition does not impair wound or enteric healing in a rat model of laparotomy and small bowel resection. MMP inhibitors are safe for use as adjuvant therapy after resection for cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Soo C, Shaw WW, Zhang X, et al. Differential expression of matrix metalloproteinases and their tissue-derived inhibitors in cutaneous wound repair. Plast Reconstr Surg 2000; 105:638–647.

    Article  PubMed  CAS  Google Scholar 

  2. Heath EI, Grochow LB. Clinical potential of matrix metalloprotease inhibitors in cancer therapy. Drugs 2000;59:1043–1055.

    Article  PubMed  CAS  Google Scholar 

  3. Seifert WF, Wobbes T, Hendriks T. Divergent patterns of matrix metalloproteinase activity during wound healing in ileum and colon. Gut 1996;39:114–119.

    Article  PubMed  CAS  Google Scholar 

  4. von Lampe B, Barthel B, Coupland SE, et al. Differential expression of matrix metalloproteinases and their tissue inhibitors in colon mucosa of patients with inflammatory bowel disease. Gut 2000;47:63–73.

    Article  Google Scholar 

  5. Raza SL, Cornelius LA. Matrix metalloproteinases: Pro- and anti-angiogenic activities. J Investig Dermatol Symp Proc 2000;5:47–54.

    Article  PubMed  CAS  Google Scholar 

  6. Agren MS. Gelatinase activity during wound healing. Br J Dermatol 1994;131:634–640.

    Article  PubMed  CAS  Google Scholar 

  7. Jones L, Ghaneh P, Humphreys M, Neoptolemos JP. The matrix metalloproteinases and their inhibitors in the treatment of pancreatic cancer. Ann N Y Acad Sci 1999;880:288–307.

    Article  PubMed  CAS  Google Scholar 

  8. Deryugina EI, Bourdon MA, Reisfeld RA, Strongin A. Remodeling of collagen matrix by human tumor cells requires activation and cell surface association of matrix metalloproteinase-2. Cancer Res 1998;58:3743–3750.

    PubMed  CAS  Google Scholar 

  9. Jimenez RE, Hartwig W, Antoniu BA, et al. Effect of matrix metalloproteinase inhibition on pancreatic cancer invasion and metastasis: An additive strategy for cancer control. Ann Surg 2000;231:644–654.

    Article  PubMed  CAS  Google Scholar 

  10. Vaalamo M, Karjalainen-Lindsberg M, Puolakkainen P, et al. Distinct expression profiles of stromelysin-2 (MMP-10), collagenase-3 (MMP-13), macrophage metalloelastase (MMP-12), and tissue inhibitor of metalloproteinases-3 (TIMP-3) in intestinal ulcerations. AmJ Pathol 1998; 152:1005–1014.

    CAS  Google Scholar 

  11. SykI, Agren MS, Adawi D, Jeppsson B. Inhibition of matrix metalloproteinases enhances breaking strength of colonic anastomoses in an experimental model. Br J Surg 2001;88:228–234.

    Article  Google Scholar 

  12. Witte MB, Thornton FJ, Kiyama T, et al. Metalloproteinase inhibitors and wound healing: A novel enhancer of wound strength. Surgery 1998;124:464–470.

    PubMed  CAS  Google Scholar 

  13. Rechardt O, Elomaa O, Vaalamo M, et al. Stromelysin-2 is upregulated during normal wound repair and is induced by cytokines. J Invest Dermatol 2000; 115:778–787.

    Article  PubMed  CAS  Google Scholar 

  14. Colandrea T, Wang L, Wille J, et al. Epidermal expression of collagenase delays wound-healing in transgenic mice. J Invest Dermatol 1998;111:1029–1033.

    Article  PubMed  Google Scholar 

  15. Okada A, Tomasetto C, Lutz Y, et al. Expression of matrix metalloproteinases during rat skin wound healing: Evidence that membrane type-1 matrix metalloproteinase is a stromal activator of pro-gelatinase A. J Cell Biol 1997;137:67–77.

    Article  PubMed  CAS  Google Scholar 

  16. Wang X, Fu X, Brown PD, Crimmin MJ, Hoffman RM. Matrix metalloproteinase inhibitor BB-94 (batimastat) inhibits human colon tumor growth and spread in a patientlike orthotopic model in nude mice. Cancer Res 1994;54:4726–4728.

    PubMed  CAS  Google Scholar 

  17. Reddy GK, Enwemeka CS. A simplified method for the analysis of hydroxyproline in biological tissues. Clin Biochem 1996;29:225–229.

    Article  PubMed  CAS  Google Scholar 

  18. Edwards CA, O’Brien WD. Modified assay for determination of hydroxyproline in a tissue hydrolyzate. Clin Chim Acta 1980;104:161–167.

    Article  PubMed  CAS  Google Scholar 

  19. Wojtowicz-Praga SM, Dickson RB, Hawkins MJ. Matrix metalloproteinase inhibitors. Invest New Drugs 1997;15:61–75.

    Article  PubMed  CAS  Google Scholar 

  20. Pilcher BK, Wang M, Qin X, et al. Role of matrix metalloproteinases and their inhibition in cutaneous wound healing and allergic contact hypersensitivity. Ann N Y Acad Sci 1999;878:12–24.

    Article  PubMed  CAS  Google Scholar 

  21. Jonsson T, Hogstrom H. Neutrophil-dependent decrease in early wound margin strength. Arch Surg 1991;126:1423–1426.

    PubMed  CAS  Google Scholar 

  22. Schwartz JD, Shamamian P, Monea S, et al. Activation of tumor cell matrix metalloproteinase-2 by neutrophil proteinases requires expression of membrane-type 1 matrix metalloproteinase. Surgery 1998;124:232–238.

    PubMed  CAS  Google Scholar 

  23. Furst MB, Stromberg BV, Blatchford GJ, Christensen MA, Thorson AG. Colonic anastomoses: Bursting strength after corticosteriod treatment. Dis Colon Rectum 1994;37:12–15.

    Article  PubMed  CAS  Google Scholar 

  24. Del Rio JV, Beck DE, Opelka FG. Chronic perioperative steroids and colonic anastomotic healing in rats. J Surg Res 1996;66:138–142.

    Article  Google Scholar 

  25. Fukuchi SG, Seeburger JL, Parquet G, Rolandelli RH. Influence of 5-fluorouracil on colonic healing and expression of transforming growth factor-beta 1. J Surg Res 1999;84:121–126.

    Article  PubMed  CAS  Google Scholar 

  26. Lawrence WT. Wound healing biology and its application to wound management. In O’Leary JP, ed. The Physiologic Basis of Surgery. Philadelphia: Williams & Wilkins, 1996, pp 118–140.

    Google Scholar 

  27. Jonsson K, Jiborn H, Zederfeldt B. Collagen metabolism in small intestinal anastomosis. AmJ Surg 1987;154:288–291.

    Article  CAS  Google Scholar 

  28. Bowers RL, Eeckhout C, Weisbrodt NW. Actomyosin, collagen, and cell hypertrophy in intestinal muscle after jejunoileal bypass. AmJ Physiol 1986;250:70–75.

    Google Scholar 

  29. Uden P, Blomquist P, Jiborn H, Zederfeldt B. Impact of long-term relative bowel rest on conditions for colonic surgery. Am J Surg 1988;156:381–385.

    Article  PubMed  CAS  Google Scholar 

  30. Kiyama T, Onda M, Tokunaga A, et al. Effect of early post-operative feeding on the healing of colonic anastomoses in the presence of intra-abdominal sepsis in rats. Dis Colon Rectum 2000;43(Suppl 10):54–58.

    Article  Google Scholar 

  31. Tani T, Tsutamoto Y, Eguchi Y, et al. Protease inhibitor reduces loss of tensile strength in rat anastomosis with peritonitis. J Surg Res 2000;88:135–141.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts

    James H. Balcom IV M.D., Tobias Keck M.D., Andrew L. Warshaw M.D., Bozena Antoniu M.S. & Carlos Fernández-del Castillo M.D.

  2. Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts

    Gregory Y. Lauwers M.D.

Authors
  1. James H. Balcom IV M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Tobias Keck M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Andrew L. Warshaw M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Bozena Antoniu M.S.
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Gregory Y. Lauwers M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Carlos Fernández-del Castillo M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Carlos Fernández-del Castillo M.D..

Additional information

Supported by the Edward D. Churchill, M.D. Resident Research Fellowship, Harvard Medical School, Boston, Massachusetts.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Balcom, J.H., Keck, T., Warshaw, A.L. et al. Perioperative matrix metalloproteinase inhibition therapy does not impair wound or anastomotic healing. J Gastrointest Surg 6, 488–495 (2002). https://doi.org/10.1016/S1091-255X(02)00015-X

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1016/S1091-255X(02)00015-X

Key words

Search

Navigation